Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Luis Buzón-Martín"'
Publikováno v:
Antibiotics, Vol 10, Iss 6, p 656 (2021)
Dalbavancin (DAL) is a lipoglycopeptide with bactericidal activity against a very wide range of Gram-positive microorganisms. It also has unique pharmacokinetic properties, namely a prolonged half-life (around 181 h), which allows a convenient weekly
Externí odkaz:
https://doaj.org/article/5a4523c40b374b158eaa8412d84f37df
Autor:
Luis, Buzon-Martín, Miguel, Montero-Baladía, Pedro, Delgado-López, David, Iglesias-Posadilla, Itziar, Astigarraga, Ana, Galacho-Harriero, Enrique, Iglesias-Julián, María, López-Veloso, Noelia, De La Torre-Ferrera, Julio César, Barraza-Bengoechea, Marta, Ubeira- Iglesias, Rodrigo, San Llorente- Sebastián, María, Colazo-Burlato, Andrés, Lorenzo-Martín, Javier, Minguito de la Iglesia, Juan Pablo, García-Muñoz, Gerardo, Hermida-Fernández, Carolina, Navarro-San Francisco, Jorge, Boado-Lama, María, Fernández-Regueras, Fernando, Callejo-Torre, Sergio, Ossa-Echeverri, Lourdes, Fisac-Cuadrado, María, Gero-Escapa, Gregoria, Megías-Lobón, Adolfo, Simón-Rodríguez, José Antonio, Fernández-Ratero
Publikováno v:
In Journal of Translational Autoimmunity 2021 4
Autor:
Luis Buzón-Martín, Carlos Dueñas Gutierrez, José Antonio Iribarren, Ignacio de los Santos, Alberto Diaz-De Santiago, Miguel Ángel Morán-Rodríguez, Guillermo Pousada, Claudia González Rico, Estela Moreno García, Eva Ferreira, Alicia Iglesias Gómez, Cristina Martín gómez, Julia gómez Barquero, Miguel V Egido Murciano, Jesús Troya
Publikováno v:
Open Forum Infectious Diseases. 9
Background Dolutegravir-based dual therapies for treating people living with HIV (PLHIV) are strategies strongly recommended in several practice guidelines. The safety and efficacy combination of Dolutegravir (DTG) plus 3TC as a switching strategy in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::473eded55336fea36bebb4dd440af335
https://doi.org/10.1093/ofid/ofac492.1093
https://doi.org/10.1093/ofid/ofac492.1093
Autor:
Jorge Monasterio Bel, Luis Buzón Martín, Carolina Navarro San Francisco, Carmen Gordón Bolaños
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 40:576-577
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac1eda9a92093ff2bac6a15524c38b1
https://doi.org/10.1016/j.eimc.2022.02.007
https://doi.org/10.1016/j.eimc.2022.02.007
Publikováno v:
Antibiotics, Vol 10, Iss 656, p 656 (2021)
E-Prints Complutense. Archivo Institucional de la UCM
Universidad Europea (UEM)
Antibiotics
E-Prints Complutense. Archivo Institucional de la UCM
Universidad Europea (UEM)
Antibiotics
Dalbavancin (DAL) is a lipoglycopeptide with bactericidal activity against a very wide range of Gram-positive microorganisms. It also has unique pharmacokinetic properties, namely a prolonged half-life (around 181 h), which allows a convenient weekly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b998b77c7b9528d708c68604a236fb42
https://eprints.ucm.es/id/eprint/72087/
https://eprints.ucm.es/id/eprint/72087/
Autor:
Luis Buzón-Martín
Publikováno v:
Aids Reviews. 22
Following the initiation of antiretroviral therapy, most HIV-infected individuals experience significant weight gain. It was originally thought to result from reduced energy consumption associated with suppression of overt virus replication. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c1c127b6e26afedf5b3b4cdb3be1ed
https://doi.org/10.24875/aidsrev.m20000036
https://doi.org/10.24875/aidsrev.m20000036
Autor:
Antonio Fernández Ortiz, Víctor Manuel Becerra-Muñoz, Sergio Raposeiras-Roubín, Marcos García Aguado, Charbel Maroun Eid, Juan José Gómez-Doblas, Emilio Alfonso, Luis A Moreno-Rondón, Álvaro Aparisi, Cristina Fernández-Pérez, Mohammad Abumayyaleh, Jia Huang, Vicente Estrada, Martino Pepe, Rodolfo Romero, Inmaculada Fernández-Rozas, Iván J. Núñez-Gil, Fabrizio Ugo, María C Viana-Llamas, Ana Carrero-Fernández, Carlos Macaya, Francesco Rametta, Gisela Feltes, Enrico Cerrato, Luis Buzón-Martín, Adelina Gonzalez, Christoph Liebetrau, Alba Mulet
Publikováno v:
Age and Ageing
Background the coronavirus disease 2019 (COVID-19) is characterized by poor outcomes and mortality, particularly in older patients. Methods post hoc analysis of the international, multicentre, ‘real-world’ HOPE COVID-19 registry. All patients age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ded0c240bb88bf61b414a380b498f83a
https://pubmed.ncbi.nlm.nih.gov/33201181
https://pubmed.ncbi.nlm.nih.gov/33201181
Publikováno v:
Chest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e018ab9253af09d4e461a89f1c0bcf
https://doi.org/10.1016/j.chest.2020.10.090
https://doi.org/10.1016/j.chest.2020.10.090
Publikováno v:
Enfermedades infecciosas y microbiologia clinica (English ed.). 37:205-206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c5338ed139a50e9100ba0373ecb37a6
https://doi.org/10.1016/j.eimce.2018.12.002
https://doi.org/10.1016/j.eimce.2018.12.002
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 37:205-206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5969f7495536f2fa6a1413a5fbcb46c
https://doi.org/10.1016/j.eimc.2018.04.003
https://doi.org/10.1016/j.eimc.2018.04.003